FDA Approves New Moderna COVID Vaccine — Clinical Trials Show It Causes Serious Adverse Events in 2.7% of Recipients
Children's Health Defense -- Toxic Exposures
Link to Medical commentator John Campbell, Ph.D., said it’s “bemusing” that the FDA could authorize a vaccine with such high risk and limited efficacy. The vaccine, mNEXSPIKE, uses the newer self-amplifying mRNA technology:
Link to Article by Brenda Baletti, Ph.D.:
2.7% IS the lie. Where have you been?
Who in their Right mind (aka SANE) thinks that it's '2.7%'?????????
I'll take an educated guess and say that it's 100%!!